Chemistry and Industry - Risperdal approved for troubled teens
Sunday, December 21st, 2008 The US Food and Drug Administration (FDA) has approved the use of Risperdal for treatment of two psychiatric disorders in children and adolescents.
Risperdal was approved to treat schizophrenia in 13-17 year olds and bipolar disorder in 10-17 year olds. Approval was granted after two six-eight week trials involving more than 500 children and adole…
